Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1236 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-09-30

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Centralized Pan-Algerian Survey on the undertreatment of hypercholesterolemia. The purpose of this study is to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Third Joint European Task Force guidelines in the survey population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups

NCT00699959

Coronary Patients Heart Failure

COMPLETED

Prevalence of Familial Hypercholesterolaemia (FH) in Italian Patients With Coronary Artery Disease

NCT03520140

Coronary Artery Disease

COMPLETED

A Prospective Cohort Study on Familial Hypercholesterolemia in Health Examination Population

NCT04958629

Familial Hypercholesterolemia

UNKNOWN

Effects of CHD Prevention on Lipoprotein Subclasses

NCT00005426

Cardiovascular Diseases Coronary Disease Heart Diseases

COMPLETED

Correlates of Angiographic Changes and Coronary Events

NCT00005433

Cardiovascular Diseases Coronary Disease Coronary Arteriosclerosis +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Centralised Pan-Algerian Survey on the undertreatment of hypercholesterolemia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypercholesterolemia Cardiovascular Disease Hypertension Diabetes Coronary Heart Disease Peripheral Arterial Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject must provide informed consent and comply with the survey procedures.
* Subject is on lipid lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.